Veritas In Silico
Kawasaki, JP · 3 known investors
Veritas In Silico develops AI-driven drug discovery platforms targeting RNA and nucleic acid-based therapeutics, partnering with pharmaceutical companies for small molecule and mRNA drug creation.
Founders & leadership
SN
Shingo NakamuraCEO
Investors · 3
In the news
- Takeda Ends Veritas In Silico Pact As mRNA Focus And Valuation Watchedfinance.yahoo.com · 2026
- Takeda continues to prune partnerships, cuts ties with mRNA-targeting Veritas In Silico - BioSpacebiospace.com · 2026
- Veritas In Silico Secures European Patent for RNA Discovery | Nasdaqnasdaq.com · 2024
- Veritas In Silico’s Strategic Shift to Specialty Pharma | Nasdaqnasdaq.com · 2024
- Veritas In Silico - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2024